Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro

Melanoma Research

Volumn 14, Issue 2, 2004, Pages 91-95

  Callejo, Sonia A ^a   Marshall, Jean Claude ^a   Cools Lartigue, Jonathan ^a   Saraiva, Vinicius S ^a   Burnier Jr , Miguel N ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Henry C Witelson Ocular Pathology Laboratory   (Canada)

Author keywords

Condition medium; Invasion; Macrophages; Melanoma inhibitory activity; Tumour macrophage interaction; Uveal melanoma

Indexed keywords

MATRIGEL; TUMOR PROTEIN;

ARTICLE; CANCER INVASION; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; HUMAN; HUMAN CELL; MACROPHAGE; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UVEA MELANOMA;

BIOLOGICAL FACTORS; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MACROPHAGES; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; SOLUBILITY; UVEAL NEOPLASMS;

EID: 2042449073     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200404000-00003     Document Type: Article

References (17)

1. Guba M, Bosserhoff A-K, Steinbauer M, Abels C, Anthuber M, Buettner R, et al. Over-expression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo. Br J Cancer 2000; 83:1216-1222.
2. Bosserhoff AK, Dreau D, Hein R, Landthaler M, Holder WD, Buettnet R. Malignant melanoma activity (MIA), a serological marker of malignant melanoma. Recent Res Cancer Res 2001; 158:158-168.
3. Bosserhoff AK, Echttenaucher B, Hein R, Buettner R. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo. Melanoma Res 2001; 11:417-421.
4. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Tumour infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma. Invest Opthalmol Visual Sci 2001; 42:1414-1421.
5. Elgert K, Alleva D, Mullins D. Tumour-induced immune dysfunction: the macrophage connection. J Leukoc Biol 1998; 64:275-290.
6. De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock G, et al. Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 1995; 62:155-161.
7. Diebold Y, Blanco G, Saornil MA, Fernandez N, Lazaro MC. Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived). Curr Eye Res 1997; 16:487-495.
8. Morilla-Grasa A, Caissie AL, Lopez R, Fernandez N, Rabano G, Ordonez JL, et al. Animal model of primary and metastatic human uveal melanoma: co-expression of vimentin and cytokeratin by melanoma cells with different metastatic potential. Invest Opthalmol Visual Sci 2002; 42:1166.
9. Eisengart C, Mestre J, Naama H, Mackrell P, Rivadeneira D, Murphy E, et al. Prostaglandins regulate melanoma-induced cytokine production in macrophages. Cellular Immunol 2000; 204:143-149.
10. Woodward JKL, Elshaw SR, Murray AK, Nichols CE, Cross N, Laws D, et al. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1α and TGF-β. Invest Ophthalmol Visual Sci 2002; 43:3144-3151.
11. Kunz-Schughart LA, Knuechel R. Tumour-associated fibroblasts (part II): functional impact on tumour tissue. Histol Histopathol 2002; 17:623-637.
12. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol 1994; 55:410-422.
13. Alleva DG, Burger CJ, Elgert KD, et al. Tumour growth increases la-macrophage synthesis of tumor necrosis factor-α and prostaglandin E2: changes in macrophage suppressor activity. J Leukoc Biol 1993; 53:550-558.
14. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56:4625-4629.
15. Schmitz C, Brenner W, Henze E, Christophers E, Hauschild A. Comparative study on the clinical use of protein S-100B and MIA in melanoma patients. Anticancer Res 2000; 20:5059-5064.
16. Bosserhoff AK, Stoll R, Sleeman JP, Bataille F, Buettner R, Holak TA. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity. Lab Invest 2003; 83:1583-1594.
17. Engers R, Gabbert HE. Mechanisms of tumour metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol 2000; 126:682-692.